{
  "@context": "aku-v2",
  "@type": "clinical-syndrome",
  "@id": "vasc:fmd:coronary",
  "metadata": {
    "version": "2.0.0",
    "created": "2026-01-07T03:17:00.000Z",
    "updated": "2026-01-07T03:17:00.000Z",
    "contributors": ["knowledge-graph-agent"],
    "confidence": 0.90,
    "status": "pending-quality-check"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pathology/genetic-disorders",
    "type": "vascular-disease",
    "difficulty": "advanced",
    "importance": "high"
  },
  "content": {
    "title": "Coronary Fibromuscular Dysplasia",
    "description": "FMD affecting coronary arteries and its clinical manifestations",
    "key_concepts": [
      {
        "concept": "Recognition",
        "details": "Increasingly recognized as cause of spontaneous coronary artery dissection (SCAD)"
      },
      {
        "concept": "Association with SCAD",
        "details": "Up to 50-75% of SCAD patients have extracoronary FMD on screening"
      },
      {
        "concept": "Screening",
        "details": "Consider screening for extracoronary FMD in SCAD patients (renal, carotid, iliac)"
      },
      {
        "concept": "Management",
        "details": "Conservative management preferred for SCAD; avoid stenting if possible"
      }
    ],
    "clinical_significance": "Coronary FMD/SCAD association has implications for systemic FMD screening"
  },
  "provenance": {
    "primary_sources": ["Saw J et al. J Am Coll Cardiol 2017"]
  }
}
